Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 718

1.

In vivo magnetic resonance imaging at 11.7 Tesla Visualized the effects of neonatal transection of infraorbital nerve upon primary and secondary trigeminal pathways in rats.

Ooi Y, Inui-Yamamoto C, Suzuki T, Nakadate H, Nagase Y, Seiyama A, Yoshioka Y, Seki J.

Brain Res. 2014 Jul 16. pii: S0006-8993(14)00942-1. doi: 10.1016/j.brainres.2014.07.013. [Epub ahead of print]

PMID:
25038563
[PubMed - as supplied by publisher]
2.

Chloroplast dysfunction causes multiple defects in cell cycle progression in the Arabidopsis crumpled leaf mutant.

Hudik E, Yoshioka Y, Domenichini S, Bourge M, Soubigout-Taconnat L, Mazubert C, Yi D, Bujaldon S, Hayashi H, De Veylder L, Bergounioux C, Benhamed M, Raynaud C.

Plant Physiol. 2014 Jul 18. pii: pp.114.242628. [Epub ahead of print]

PMID:
25037213
[PubMed - as supplied by publisher]
3.

On plant detection of intact tomato fruits using image analysis and machine learning methods.

Yamamoto K, Guo W, Yoshioka Y, Ninomiya S.

Sensors (Basel). 2014 Jul 9;14(7):12191-206. doi: 10.3390/s140712191.

PMID:
25010694
[PubMed - in process]
Free Article
4.

Asian Dust Particles Induce Macrophage Inflammatory Responses via Mitogen-Activated Protein Kinase Activation and Reactive Oxygen Species Production.

Higashisaka K, Fujimura M, Taira M, Yoshida T, Tsunoda S, Baba T, Yamaguchi N, Nabeshi H, Yoshikawa T, Nasu M, Yoshioka Y, Tsutsumi Y.

J Immunol Res. 2014;2014:856154. doi: 10.1155/2014/856154. Epub 2014 May 29.

PMID:
24987712
[PubMed - in process]
Free PMC Article
5.

Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells.

Ono M, Kosaka N, Tominaga N, Yoshioka Y, Takeshita F, Takahashi RU, Yoshida M, Tsuda H, Tamura K, Ochiya T.

Sci Signal. 2014 Jul 1;7(332):ra63. doi: 10.1126/scisignal.2005231.

PMID:
24985346
[PubMed - in process]
6.

Impact of intraluminal brachytherapy on survival outcome for radiation therapy for unresectable biliary tract cancer: a propensity-score matched-pair analysis.

Yoshioka Y, Ogawa K, Oikawa H, Onishi H, Kanesaka N, Tamamoto T, Kosugi T, Hatano K, Kobayashi M, Ito Y, Takayama M, Takemoto M, Karasawa K, Nagakura H, Imai M, Kosaka Y, Yamazaki H, Isohashi F, Nemoto K, Nishimura Y; Japanese Radiation Oncology Study Group (JROSG).

Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):822-9. doi: 10.1016/j.ijrobp.2014.04.020.

PMID:
24969796
[PubMed - in process]
7.

Dosimetry analyses comparing high-dose-rate brachytherapy, administered as monotherapy for localized prostate cancer, with stereotactic body radiation therapy simulated using CyberKnife.

Fukuda S, Seo Y, Shiomi H, Yamada Y, Ogata T, Morimoto M, Konishi K, Yoshioka Y, Ogawa K.

J Radiat Res. 2014 Jun 23. pii: rru048. [Epub ahead of print]

PMID:
24957754
[PubMed - as supplied by publisher]
Free Article
8.

Ephrin receptor A10 is a promising drug target potentially useful for breast cancers including triple negative breast cancers.

Nagano K, Maeda Y, Kanasaki SI, Watanabe T, Yamashita T, Inoue M, Higashisaka K, Yoshioka Y, Abe Y, Mukai Y, Kamada H, Tsutsumi Y, Tsunoda SI.

J Control Release. 2014 Jun 16;189C:72-79. doi: 10.1016/j.jconrel.2014.06.010. [Epub ahead of print]

PMID:
24946238
[PubMed - as supplied by publisher]
9.

Long-term results of intraoperative extracorporeal irradiation of autogenous bone grafts on primary bone and soft tissue malignancies.

Hayashi K, Araki N, Koizumi M, Suzuki O, Seo Y, Naka N, Isohashi F, Myoui A, Yoshioka Y, Teshima T, Ueda T, Yoshikawa H, Ogawa K.

Acta Oncol. 2014 Jun 16:1-4. [Epub ahead of print] No abstract available.

PMID:
24930390
[PubMed - as supplied by publisher]
10.

Eph receptor A10 has a potential as a target for a prostate cancer therapy.

Nagano K, Yamashita T, Inoue M, Higashisaka K, Yoshioka Y, Abe Y, Mukai Y, Kamada H, Tsutsumi Y, Tsunoda S.

Biochem Biophys Res Commun. 2014 Jul 18;450(1):545-9. doi: 10.1016/j.bbrc.2014.06.007. Epub 2014 Jun 9.

PMID:
24924629
[PubMed - in process]
11.

Role of novel risk classification method, Prostate Cancer Risk Index (PRIX) for clinically localized prostate cancer after high-dose-rate interstitial brachytherapy as monotherapy.

Yoshida K, Yamazaki H, Nakamura S, Masui K, Kotsuma T, Akiyama H, Tanaka E, Yoshioka Y.

Anticancer Res. 2014 Jun;34(6):3077-81.

PMID:
24922676
[PubMed - in process]
12.

Intercellular Communication by Extracellular Vesicles and Their MicroRNAs in Asthma.

Fujita Y, Yoshioka Y, Ito S, Araya J, Kuwano K, Ochiya T.

Clin Ther. 2014 Jun 1;36(6):873-881. doi: 10.1016/j.clinthera.2014.05.006. Epub 2014 Jun 6. Review.

PMID:
24909737
[PubMed - as supplied by publisher]
13.

Menstrual cyclic change of metastin/GPR54 in endometrium.

Baba T, Kang HS, Hosoe Y, Kharma B, Abiko K, Matsumura N, Hamanishi J, Yamaguchi K, Yoshioka Y, Koshiyama M, Mandai M, Murphy SK, Konishi I.

Med Mol Morphol. 2014 Jun 8. [Epub ahead of print]

PMID:
24908069
[PubMed - as supplied by publisher]
14.

[Nano-safety science for sustainable nanotechnology].

Yoshioka Y, Tsutsumi Y.

Yakugaku Zasshi. 2014;134(6):737-42. Japanese.

PMID:
24882650
[PubMed - in process]
Free Article
15.

[Recent topics on development of nanomaterials and nano-safety science].

Yoshioka Y, Tsutsumi Y.

Yakugaku Zasshi. 2014;134(6):721-2. Japanese. No abstract available.

PMID:
24882647
[PubMed - in process]
Free Article
16.

High-dose-rate interstitial brachytherapy in combination with androgen deprivation therapy for prostate cancer : Are high-risk patients good candidates?

Yoshida K, Yamazaki H, Takenaka T, Kotsuma T, Yoshida M, Masui K, Yoshioka Y, Narumi Y, Oka T, Tanaka E.

Strahlenther Onkol. 2014 May 17. [Epub ahead of print]

PMID:
24838407
[PubMed - as supplied by publisher]
17.

Olfactory plays a key role in spatiotemporal pathogenesis of cerebral malaria.

Zhao H, Aoshi T, Kawai S, Mori Y, Konishi A, Ozkan M, Fujita Y, Haseda Y, Shimizu M, Kohyama M, Kobiyama K, Eto K, Nabekura J, Horii T, Ishino T, Yuda M, Hemmi H, Kaisho T, Akira S, Kinoshita M, Tohyama K, Yoshioka Y, Ishii KJ, Coban C.

Cell Host Microbe. 2014 May 14;15(5):551-63. doi: 10.1016/j.chom.2014.04.008.

PMID:
24832450
[PubMed - in process]
18.

High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective.

Yoshioka Y, Suzuki O, Otani Y, Yoshida K, Nose T, Ogawa K.

J Contemp Brachytherapy. 2014 Mar;6(1):91-8. doi: 10.5114/jcb.2014.42026. Epub 2014 Apr 3. Review.

PMID:
24790627
[PubMed]
Free PMC Article
19.

High-dose-rate interstitial brachytherapy for mobile tongue cancer: preliminary results of a dose reduction trial.

Akiyama H, Yoshida K, Yamazaki H, Takenaka T, Kotsuma T, Masui K, Yoshioka Y, Arika T, Shimizutani K, Tanaka E.

J Contemp Brachytherapy. 2014 Mar;6(1):10-4. doi: 10.5114/jcb.2014.40726. Epub 2014 Feb 19.

PMID:
24790616
[PubMed]
Free PMC Article
20.

Dark side of the exosome: the role of the exosome in cancer metastasis and targeting the exosome as a strategy for cancer therapy.

Kosaka N, Yoshioka Y, Tominaga N, Hagiwara K, Katsuda T, Ochiya T.

Future Oncol. 2014 Mar;10(4):671-81. doi: 10.2217/fon.13.222.

PMID:
24754596
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk